Answers are grounded in this paper and cite their sources.
Cycle number of adjuvant FOLFOX is a significant prognostic factor for stage III colon cancer patients. At least 8 cycles are needed to have an overall survival benefit, and 7 to disease-free survival.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: